Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition Vol. 99 No. 4 December 1969, pp. 446-448
Copyright
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laastuen, L.
Right arrow Articles by Todd, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laastuen, L.
Right arrow Articles by Todd, W. R.

Rat Liver Glycogen-lowering Activity of Fed Creatine — A Retraction1, 2,

Lester Laastuen and W. R. Todd

University of Oregon Medical School, Department of Biochemistry, Portland, Oregon 97201

Earlier studies led us to report that feeding rats a semipurified diet containing 1% creatine for 20 hours brought about a marked decrease in liver glycogen (from 4% to 1% wet weight). The Practical Grade creatine (Eastman No. P951, Lot 12) was found to contain a readily separable impurity, 1,1-dimethylbiguanide which was responsible for this action and highly active at a level of 0.02% of the diet. Authentic samples of the biguanide as well as a number of other guanidine derivatives were found to possess this physiological action when fed at a level of 0.01% of the ration. The purified creatine (three recrystallizations) and other creatine samples had no such effect when fed under the same conditions. Dimethylbiguanide injected intraperitoneally caused a precipitous drop in liver glycogen in the following 4 hours. From these data and the reports of other workers it is concluded that the results are due to drug inhibition of gluconeogenesis.


1 This investigation was supported in part by the Medical Research Foundation of Oregon, Grant 685, and by Public Health Service Research Grant no. AM-04336 from the National Institute of Arthritis and Metabolic Diseases.

2 Presented in part at the Northwest Regional Meeting of the American Chemical Society, Salt Lake City, June 12–13, 1969, 24th Annual Northwest Meeting, Abstract no. 57.

Manuscript received 11 August 1969.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]